Vaxcyte Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	173.96	387.88	397.45	834.66	68.99
Short-Term Investments	1,387	1,359	682.78	96.72	176.99
Cash & Short-Term Investments	1,561	1,747	1,080	931.38	245.97
Cash Growth	-10.66%	61.75%	15.98%	278.65%	-36.31%
Other Receivables	46.56	23.08	3.6	3.88	1.2
Receivables	46.56	23.08	3.6	3.88	1.2
Prepaid Expenses	17.04	15.73	6.16	5.31	9.18
Other Current Assets	2.8	1.96	5.97	1.99	-
Total Current Assets	1,627	1,788	1,096	942.56	256.35
Property, Plant & Equipment	373.38	270.15	110.62	31.65	35.91
Long-Term Investments	881.66	1,388	162.68	26.55	27.12
Long-Term Deferred Charges	-	-	-	-	0.5
Other Long-Term Assets	120.31	65.68	38.67	5.43	4.46
Total Assets	3,003	3,511	1,408	1,006	324.34
Accounts Payable	70.9	48.45	14.59	9.8	6.76
Accrued Expenses	128.72	85.84	123.64	24.82	16.68
Current Portion of Leases	6.12	5.89	7.11	5.91	5.28
Total Current Liabilities	205.75	140.18	145.34	40.53	28.72
Long-Term Leases	111.36	65.22	22.11	12.03	11.51
Other Long-Term Liabilities	0.1	0.1	-	0.01	0.1
Total Liabilities	317.21	205.5	167.45	52.57	40.32
Common Stock	0.13	0.13	0.1	0.08	0.06
Additional Paid-In Capital	4,839	4,698	2,165	1,476	582.84
Retained Earnings	-2,155	-1,388	-924.39	-522.13	-298.64
Comprehensive Income & Other	1.59	-3.87	0.18	-0.36	-0.24
Total Common Equity	2,686	3,306	1,240	953.61	284.02
Shareholders' Equity	2,686	3,306	1,240	953.61	284.02
Total Liabilities & Equity	3,003	3,511	1,408	1,006	324.34
Total Debt	117.48	71.11	29.22	17.94	16.78
Net Cash (Debt)	1,443	1,676	1,051	913.44	229.19
Net Cash Growth	-13.88%	59.48%	15.06%	298.55%	-40.66%
Net Cash Per Share	10.61	13.74	10.82	14.08	4.41
Filing Date Shares Outstanding	143.92	128.76	108.41	80.03	56.31
Total Common Shares Outstanding	131.06	124.89	95.36	79.47	53.03
Working Capital	1,422	1,648	950.62	902.03	227.63
Book Value Per Share	20.49	26.47	13.01	12.00	5.36
Tangible Book Value	2,686	3,306	1,240	953.61	284.02
Tangible Book Value Per Share	20.49	26.47	13.01	12.00	5.36
Machinery	65.82	58.15	35.62	15.12	11.5
Construction In Progress	217.08	151.79	51.82	-	-
Leasehold Improvements	7.24	4.38	1.46	1.35	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q